As always another professional preso.. some key takeaways I spotted..
"Competitive products with less ideal safety profiles and potentially poorer efficacy, have generated more than US $1bn per annum"
"BTX 1503 is a safe and well tolerated topical acne treatment that potentially addresses all the key causes of acne" (Loved the use of the world potentially) -
"Papulopustular rosacea is a chronic skin disease characterised by redness (inflammation) and acne like break-out
Hints everywherre.. One must ask why the rosacea now? Perhaps the 'acne like break-out' is the key takeaway? Why chase a similiar market otherwise?
Join the dots..
Phase 1B for BTX 1702 will only take 6 weeks also.. then straight on to phase 2 no doubt.
Also great to see some patent explanation.. that's the beauty of having an ex patent attorney I guess..
Not sure what else we can ask from management.
Great work.
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Investor Presentation
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
8.82%
!
31.0¢

Ann: Botanix Investor Presentation, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.0¢ |
Change
-0.030(8.82%) |
Mkt cap ! $607.9M |
Open | High | Low | Value | Volume |
35.0¢ | 35.0¢ | 31.0¢ | $3.301M | 9.964M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 570285 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 30000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.375 |
1 | 40000 | 0.350 |
5 | 52451 | 0.320 |
1 | 2000 | 0.315 |
23 | 707707 | 0.310 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 25000 | 1 |
0.270 | 5615 | 1 |
0.280 | 235000 | 2 |
0.290 | 270000 | 2 |
0.295 | 133989 | 3 |
Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
AGC
AUSTRALIAN GOLD AND COPPER LTD
Glen Diemar, MD
Glen Diemar
MD
SPONSORED BY The Market Online